Gadoteridol
Cat. No.:YN481913
| 产品名称: | Gadoteridol | 
| CAS No.: | 120066-54-8 | 
| Chemical Name: | [10-[2-(hydroxy-κO)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7]-gadolinium | 
| Synonyms: | 钆特醇; SQ-32692; Gd-HP-DO3A | 
| 分子量: | 557.68 | 
| 分子式: | C₁₇H₂₈GdN₄O₇ | 
| SMILES: | CC1O[Gd+3]2([N]3(CC4)CC5=O)([N]6(CC7)CC([O-]2)=O)([N]47CC8=O)([O-]8)([O-]5)[N](CC6)(CC3)C1 | 
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. | 
| 运输: | Room temperature in continental US; may vary elsewhere. | 
| 产品描述: | Gadoteridol是一种含钆基的MRI造影剂,用于中枢神经系统成像。 | 
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: | 
Runge, V.M., Gelblum, D.Y., and Jacobson, S.Gd HP-DO3A—experimental evaluation in brain and renal MRMagn. Reson. Imaging9(1),79-87(1991)
Filippi, M., Boido, M., Pasquino, C., et al.Successful in vivo MRI tracking of MSCs labeled with gadoteridol in a spinal cord Injury experimental modelExp. Neurol.282,66-77(2016)